AMGN reports Repatha reduces risk of death in high-risk patients
Amgen said its Repatha reduced risk of death in patients at high risk for a first heart attack or stroke.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.